Literature DB >> 35357470

Impact of longitudinal data-completeness of electronic health record data on risk score misclassification.

Yinzhu Jin1, Sebastian Schneeweiss1, Dave Merola1, Kueiyu Joshua Lin1,2.   

Abstract

BACKGROUND: Electric health record (EHR) discontinuity, that is, receiving care outside of a given EHR system, can lead to substantial information bias. We aimed to determine whether a previously described EHR-continuity prediction model can reduce the misclassification of 4 commonly used risk scores in pharmacoepidemiology.
METHODS: The study cohort consists of patients aged ≥ 65 years identified in 2 US EHR systems linked with Medicare claims data from 2007 to 2017. We calculated 4 risk scores, CHAD2DS2-VASc, HAS-BLED, combined comorbidity score (CCS), claims-based frailty index (CFI) based on information recorded in the 365 days before cohort entry, and assessed their misclassification by comparing score values based on EHR data alone versus the linked EHR-claims data. CHAD2DS2-VASc and HAS-BLED were assessed in atrial fibrillation (AF) patients, whereas CCS and CFI were assessed in the general population.
RESULTS: Our study cohort included 204 014 patients (26 537 with nonvalvular AF) in system 1 and 115 726 patients (15 529 with nonvalvular AF) in system 2. Comparing the low versus high predicted EHR continuity in system 1, the proportion of patients with misclassification of ≥2 categories improved from 55% to 16% for CHAD2DS2-VASc, from 55% to 12% for HAS-BLED, from 37% to 16% for CCS, and from 10% to 2% for CFI. A similar pattern was found in system 2.
CONCLUSIONS: Using a previously described prediction model to identify patients with high EHR continuity may significantly reduce misclassification for the commonly used risk scores in EHR-based comparative studies.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  care continuum; data completeness; data leakage; loyalty cohort; patient connectedness

Mesh:

Substances:

Year:  2022        PMID: 35357470      PMCID: PMC9196679          DOI: 10.1093/jamia/ocac043

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   7.942


  32 in total

1.  Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.

Authors:  Gregory Y H Lip; Deirdre A Lane
Journal:  Eur Heart J       Date:  2015-09-08       Impact factor: 29.983

2.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.

Authors:  Jenny W Sun; James R Rogers; Qoua Her; Emily C Welch; Catherine A Panozzo; Sengwee Toh; Joshua J Gagne
Journal:  Med Care       Date:  2018-09       Impact factor: 2.983

4.  A combined comorbidity score predicted mortality in elderly patients better than existing scores.

Authors:  Joshua J Gagne; Robert J Glynn; Jerry Avorn; Raisa Levin; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

5.  Out-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research.

Authors:  Kueiyu Joshua Lin; Robert J Glynn; Daniel E Singer; Shawn N Murphy; Joyce Lii; Sebastian Schneeweiss
Journal:  Epidemiology       Date:  2018-05       Impact factor: 4.822

6.  Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.

Authors:  François Laliberté; Michel Cloutier; Winnie W Nelson; Craig I Coleman; Dominic Pilon; William H Olson; C V Damaraju; Jeffrey R Schein; Patrick Lefebvre
Journal:  Curr Med Res Opin       Date:  2014-04-02       Impact factor: 2.580

7.  The Impact of Frailty on Long-Term Patient-Oriented Outcomes after Emergency General Surgery: A Retrospective Cohort Study.

Authors:  Katherine C Lee; Jocelyn Streid; Dan Sturgeon; Stuart Lipsitz; Joel S Weissman; Ronnie A Rosenthal; Dae H Kim; Susan L Mitchell; Zara Cooper
Journal:  J Am Geriatr Soc       Date:  2020-02-11       Impact factor: 5.562

8.  Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation.

Authors:  Krista F Huybrechts; Chandrasekar Gopalakrishnan; Dorothee B Bartels; Kristina Zint; Venkatesh K Gurusamy; Joan Landon; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2020-01-24       Impact factor: 6.875

9.  Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.

Authors:  Seoyoung C Kim; Daniel H Solomon; James R Rogers; Sara Gale; Micki Klearman; Khaled Sarsour; Sebastian Schneeweiss
Journal:  Arthritis Rheumatol       Date:  2017-04-28       Impact factor: 10.995

10.  External Validation of an Algorithm to Identify Patients with High Data-Completeness in Electronic Health Records for Comparative Effectiveness Research.

Authors:  Kueiyu Joshua Lin; Gary E Rosenthal; Shawn N Murphy; Kenneth D Mandl; Yinzhu Jin; Robert J Glynn; Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2020-02-04       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.